Last edition
News about "Claus Jepsen "
Lupin Secures EMA Approval for Expanded NaMuscla Pediatric Use
Lupin has received EMA approval to expand the pediatric indication of NaMuscla, including two new capsule strengths of 62 mg and 83 mg.
Claus Jepsen | 03/07/2026 | By News Bureau | 324
Lupin Announces Appointment of Claus Jepsen as President-Global Specialty
Claus joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for Rare Diseases.
Claus Jepsen | 22/10/2024 | By Aishwarya | 455
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy